insights_auto
Bakit bumaba ang 000739 8.67%?
Tingnan ang Higit pang Detalyechevron_right
000739:SHE
Apeloa Pharmaceutical Co Ltd
CN¥21.39
arrow_downward
-8.67%(-2.03) 1D
Okt 19, 12:26:21 PM GMT+8 · CNY
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 000739...
Buksan
CN¥23.02
Mataas
CN¥23.57
Mababa
CN¥21.08
Mkt. cap
27.13B
Avg. na dami
16.57M
Dami
24.45M
Dividend
1.76%
Bawat tatlong buwang dividend
CN¥0.09
Petsa ng ex-dividend
Okt 8, 2026
P/E ratio
29.03
Mataas nang 52-wk
CN¥28.50
Mababa nang 52-wk
CN¥14.89
EPS
CN¥0.74
Mga natitirang share
1.16B
Bilang ng mga empleyado
7K
Buksan
CN¥23.02
Mataas
CN¥23.57
Mababa
CN¥21.08
Mkt. cap
27.13B
Avg. na dami
16.57M
Dami
24.45M
Dividend
1.76%
Bawat tatlong buwang dividend
CN¥0.09
Petsa ng ex-dividend
Okt 8, 2026
P/E ratio
29.03
Mataas nang 52-wk
CN¥28.50
Mababa nang 52-wk
CN¥14.89
EPS
CN¥0.74
Mga natitirang share
1.16B
Bilang ng mga empleyado
7K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TradingView
·
20 minuto ang nakalipas
No ‘Black Monday’? Nasdaq, S&P 500, Dow Futures Spike As Big Tech Earnings Loom This Week — Retail Stays Cautious
BigGo Finance
·
22 minuto ang nakalipas
South Korea's FSS Chief Says Solidigm's Nasdaq Listing Would Constitute Duplicate Listing, Hints at Conveying Concerns to SK Hynix
Bloomberg.com
·
6 oras ang nakalipas
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
Tungkol sa Apeloa Pharmaceutical Co Ltd